Mainz Biomed B.V. (MYNZ) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 373.22K | 520.77K | 214.76K | 500.21K | 251.4K | 278.48K | 160.04K | 417.31K | 246.78K | 246.78K | 70.35K | 70.35K |
| Revenue Growth % | 73.78% | 4.11% | -14.57% | 79.62% | 57.09% | -33.27% | -35.15% | 69.1% | 250.8% | 250.8% | - | - |
| Cost of Goods Sold | 117.37K | 201.74K | 163.49K | 222.33K | 217.99K | 129.74K | 334.95K | 64.77K | 185.24K | 185.24K | 85.67K | 85.67K |
| COGS % of Revenue | 31.45% | 38.74% | 76.13% | 44.45% | 86.71% | 46.59% | 209.3% | 15.52% | 75.06% | 75.06% | 121.77% | 121.77% |
| Gross Profit | 255.84K | 319.04K | 40.25K | 277.88K | 33.41K | 148.74K | -174.92K | 352.54K | 61.54K | 61.54K | -15.32K | -15.32K |
| Gross Margin % | 68.55% | 61.26% | 18.74% | 55.55% | 13.29% | 53.41% | -109.3% | 84.48% | 24.94% | 24.94% | -21.77% | -21.77% |
| Gross Profit Growth % | 535.62% | 14.81% | 20.48% | 86.82% | 119.1% | -57.81% | -384.22% | 472.84% | 501.76% | 501.76% | - | - |
| Operating Expenses | 9.14M | 10.13M | 13.9M | 13.25M | 12.45M | 13.91M | 11.08M | 240.75K | 455.55K | 455.55K | 254.45K | 254.45K |
| OpEx % of Revenue | 2450.02% | 1944.49% | 6472.94% | 2649.5% | 4952.93% | 4993.32% | 6925.49% | 57.69% | 184.59% | 184.59% | 361.7% | 361.7% |
| Selling, General & Admin | 5.89M | 6.88M | 8.6M | 7.94M | 9.47M | 13.34M | 9.03M | 240.75K | 284.38K | 284.38K | 187.93K | 187.93K |
| SG&A % of Revenue | 1578.48% | 1321.83% | 4003.96% | 1587.36% | 3765.93% | 4791.37% | 5645.26% | 57.69% | 115.23% | 115.23% | 267.14% | 267.14% |
| Research & Development | 2.6M | 3.24M | 3.85M | 5.25M | 2.96M | 696.29K | 260.54K | 206.15K | 155.92K | 155.92K | 62.58K | 62.58K |
| R&D % of Revenue | 695.68% | 622.66% | 1794.56% | 1049.59% | 1179.09% | 250.03% | 162.8% | 49.4% | 63.18% | 63.18% | 88.96% | 88.96% |
| Other Operating Expenses | 656.34K | 0 | 1000K | 62.74K | 0 | 0 | 10.75K | 10.75K | 15.24K | 15.24K | 3.94K | 3.94K |
| Operating Income | -8.89M | -9.81M | -12.23M | -12.98M | -12.28M | -13.9M | -9.47M | -240.75K | -178.15K | -178.15K | -187.87K | -187.87K |
| Operating Margin % | -2381.47% | -1883.23% | -5695.18% | -2593.94% | -4884.28% | -4989.88% | -5917.36% | -57.69% | -72.19% | -72.19% | -267.06% | -267.06% |
| Operating Income Growth % | 27.33% | 24.41% | 0.39% | 6.63% | -29.66% | -5671.89% | -5215.71% | -35.14% | 5.17% | 5.17% | - | - |
| EBITDA | -8.21M | -9.47M | -11.77M | -12.4M | -11.87M | -13.84M | -9.5M | -205.91K | -165.12K | -165.12K | -182.7K | -182.7K |
| EBITDA Margin % | -2199.03% | -1818.68% | -5481.08% | -2479.05% | -4723.42% | -4970.12% | -5935.02% | -49.34% | -66.91% | -66.91% | -259.71% | -259.71% |
| EBITDA Growth % | 30.28% | 23.62% | 0.87% | 10.41% | -25.02% | -6621.61% | -5652.46% | -24.71% | 9.63% | 9.63% | - | - |
| D&A (Non-Cash Add-back) | 680.89K | 336.15K | 459.82K | 574.7K | 404.4K | 55.02K | -28.26K | 34.84K | 13.04K | 13.04K | 5.17K | 5.17K |
| EBIT | -10.77M | -9.81M | -13.07M | -12.98M | -12.2M | -13.9M | -9.47M | -254.63K | 0 | 0 | -188.78K | -188.78K |
| Net Interest Income | -415.76K | -659.47K | -559.58K | -146.72K | -289.32K | 231.83K | 85.33K | 84.26K | -134.4K | -134.4K | -50.48K | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 231.83K | 170.12K | 169.05K | 0 | 0 | 0 | 0 |
| Interest Expense | 1.08M | 659.47K | 662.86K | 146.72K | 289.32K | 0 | 84.79K | 84.79K | 134.4K | 134.4K | 50.48K | 50.48K |
| Other Income/Expense | -1.74M | -1.22M | 747.95K | -146.72K | 38.31K | 18.4K | -1.96M | -2 | -115.3K | -115.3K | -51.39K | -51.39K |
| Pretax Income | -10.63M | -11.02M | -5.18M | -13.12M | -12.51M | -13.88M | -11.43M | -240.75K | -293.45K | -293.45K | -239.26K | -239.26K |
| Pretax Margin % | -2847.37% | -2116.81% | -2413.53% | -2623.28% | -4976.16% | -4983.27% | -7141.08% | -57.69% | -118.91% | -118.91% | -340.11% | -340.11% |
| Income Tax | 0 | 0 | 0 | 146.72K | 0 | 0 | 0 | 0 | 19.1K | 19.1K | 0 | -909 |
| Effective Tax Rate % | 0% | 0% | 0% | -1.12% | 0% | 0% | 0% | 0% | -6.51% | -6.51% | 0% | 0.38% |
| Net Income | -10.63M | -11.02M | -5.18M | -13.27M | -12.58M | -13.88M | -11.43M | -240.75K | -293.45K | -293.45K | -239.26K | -239.26K |
| Net Margin % | -2847.37% | -2116.81% | -2413.53% | -2652.61% | -5002.17% | -4983.27% | -7141.08% | -57.69% | -118.91% | -118.91% | -340.11% | -340.11% |
| Net Income Growth % | -105.02% | 16.92% | 58.78% | 4.39% | -10.04% | -5664.2% | -3794.52% | 17.96% | -22.65% | -22.65% | - | - |
| Net Income (Continuing) | -10.63M | -11.02M | -5.18M | 0 | -12.51M | -13.88M | -11.43M | -240.75K | 0 | 0 | -239.26K | -239.26K |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -7.71 | -19.73 | -11.73 | -0.90 | -0.89 | -0.98 | -1.30 | -0.02 | -0.03 | -0.03 | -0.02 | -0.02 |
| EPS Growth % | 34.27% | -2092.22% | -1217.98% | 8.16% | 31.54% | -4800% | -5100% | 20% | -22.55% | -22.55% | - | - |
| EPS (Basic) | -7.71 | -19.73 | -11.73 | -0.90 | -0.87 | -1.00 | -1.30 | -0.02 | -0.03 | -0.03 | -0.02 | -0.02 |
| Diluted Shares Outstanding | 968.23K | 558.75K | 442.04K | 29.38M | 14.16M | 14.29M | 8.81M | 12.01M | 23.42M | 23.42M | 11.71M | 11.71M |
| Basic Shares Outstanding | 968.23K | 558.75K | 442.04K | 29.38M | 14.16M | 13.82M | 8.81M | 12.01M | 23.42M | 23.42M | 11.71M | 11.71M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |